How does COVID-19 kill? Uncertainty is hampering doctors' ability to choose treatments.
Identifieur interne : 000251 ( PubMed/Curation ); précédent : 000250; suivant : 000252How does COVID-19 kill? Uncertainty is hampering doctors' ability to choose treatments.
Auteurs : Heidi LedfordSource :
- Nature [ 1476-4687 ] ; 2020.
Descripteurs français
- KwdFr :
- Anticorps monoclonaux humanisés (pharmacologie), Anticorps monoclonaux humanisés (usage thérapeutique), Essais contrôlés randomisés comme sujet, Humains, Immunosuppresseurs (pharmacologie), Immunosuppresseurs (usage thérapeutique), Incertitude, Infections à coronavirus (anatomopathologie), Infections à coronavirus (immunologie), Infections à coronavirus (mortalité), Infections à coronavirus (traitement médicamenteux), Interleukine-6 (antagonistes et inhibiteurs), Interleukine-6 (immunologie), Lymphocytes T (), Lymphocytes T (immunologie), Macrophages (), Macrophages (immunologie), Médecins (psychologie), Pandémies, Pneumopathie virale (anatomopathologie), Pneumopathie virale (immunologie), Pneumopathie virale (mortalité), Pneumopathie virale (traitement médicamenteux), Prise de décision clinique, Stéroïdes (administration et posologie), Stéroïdes (effets indésirables), Stéroïdes (pharmacologie), Stéroïdes (usage thérapeutique).
- MESH :
- administration et posologie : Stéroïdes.
- anatomopathologie : Infections à coronavirus, Pneumopathie virale.
- antagonistes et inhibiteurs : Interleukine-6.
- effets indésirables : Stéroïdes.
- immunologie : Infections à coronavirus, Interleukine-6, Lymphocytes T, Macrophages, Pneumopathie virale.
- mortalité : Infections à coronavirus, Pneumopathie virale.
- pharmacologie : Anticorps monoclonaux humanisés, Immunosuppresseurs, Stéroïdes.
- psychologie : Médecins.
- traitement médicamenteux : Infections à coronavirus, Pneumopathie virale.
- usage thérapeutique : Anticorps monoclonaux humanisés, Immunosuppresseurs, Stéroïdes.
- Essais contrôlés randomisés comme sujet, Humains, Incertitude, Lymphocytes T, Macrophages, Pandémies, Prise de décision clinique.
English descriptors
- KwdEn :
- Antibodies, Monoclonal, Humanized (pharmacology), Antibodies, Monoclonal, Humanized (therapeutic use), Betacoronavirus (drug effects), Betacoronavirus (immunology), Betacoronavirus (pathogenicity), Clinical Decision-Making, Coronavirus Infections (drug therapy), Coronavirus Infections (immunology), Coronavirus Infections (mortality), Coronavirus Infections (pathology), Humans, Immunosuppressive Agents (pharmacology), Immunosuppressive Agents (therapeutic use), Interleukin-6 (antagonists & inhibitors), Interleukin-6 (immunology), Macrophages (drug effects), Macrophages (immunology), Pandemics, Physicians (psychology), Pneumonia, Viral (drug therapy), Pneumonia, Viral (immunology), Pneumonia, Viral (mortality), Pneumonia, Viral (pathology), Randomized Controlled Trials as Topic, Steroids (administration & dosage), Steroids (adverse effects), Steroids (pharmacology), Steroids (therapeutic use), T-Lymphocytes (drug effects), T-Lymphocytes (immunology), Uncertainty.
- MESH :
- chemical , administration & dosage : Steroids.
- chemical , adverse effects : Steroids.
- chemical , antagonists & inhibitors : Interleukin-6.
- chemical , immunology : Interleukin-6.
- chemical , pharmacology : Antibodies, Monoclonal, Humanized, Immunosuppressive Agents, Steroids.
- chemical , therapeutic use : Antibodies, Monoclonal, Humanized, Immunosuppressive Agents, Steroids.
- drug effects : Betacoronavirus, Macrophages, T-Lymphocytes.
- drug therapy : Coronavirus Infections, Pneumonia, Viral.
- immunology : Betacoronavirus, Coronavirus Infections, Macrophages, Pneumonia, Viral, T-Lymphocytes.
- mortality : Coronavirus Infections, Pneumonia, Viral.
- pathogenicity : Betacoronavirus.
- pathology : Coronavirus Infections, Pneumonia, Viral.
- psychology : Physicians.
- Clinical Decision-Making, Humans, Pandemics, Randomized Controlled Trials as Topic, Uncertainty.
DOI: 10.1038/d41586-020-01056-7
PubMed: 32273618
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000251
Links to Exploration step
pubmed:32273618Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">How does COVID-19 kill? Uncertainty is hampering doctors' ability to choose treatments.</title>
<author><name sortKey="Ledford, Heidi" sort="Ledford, Heidi" uniqKey="Ledford H" first="Heidi" last="Ledford">Heidi Ledford</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32273618</idno>
<idno type="pmid">32273618</idno>
<idno type="doi">10.1038/d41586-020-01056-7</idno>
<idno type="wicri:Area/PubMed/Corpus">000251</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000251</idno>
<idno type="wicri:Area/PubMed/Curation">000251</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000251</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">How does COVID-19 kill? Uncertainty is hampering doctors' ability to choose treatments.</title>
<author><name sortKey="Ledford, Heidi" sort="Ledford, Heidi" uniqKey="Ledford H" first="Heidi" last="Ledford">Heidi Ledford</name>
</author>
</analytic>
<series><title level="j">Nature</title>
<idno type="eISSN">1476-4687</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibodies, Monoclonal, Humanized (pharmacology)</term>
<term>Antibodies, Monoclonal, Humanized (therapeutic use)</term>
<term>Betacoronavirus (drug effects)</term>
<term>Betacoronavirus (immunology)</term>
<term>Betacoronavirus (pathogenicity)</term>
<term>Clinical Decision-Making</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Coronavirus Infections (immunology)</term>
<term>Coronavirus Infections (mortality)</term>
<term>Coronavirus Infections (pathology)</term>
<term>Humans</term>
<term>Immunosuppressive Agents (pharmacology)</term>
<term>Immunosuppressive Agents (therapeutic use)</term>
<term>Interleukin-6 (antagonists & inhibitors)</term>
<term>Interleukin-6 (immunology)</term>
<term>Macrophages (drug effects)</term>
<term>Macrophages (immunology)</term>
<term>Pandemics</term>
<term>Physicians (psychology)</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>Pneumonia, Viral (immunology)</term>
<term>Pneumonia, Viral (mortality)</term>
<term>Pneumonia, Viral (pathology)</term>
<term>Randomized Controlled Trials as Topic</term>
<term>Steroids (administration & dosage)</term>
<term>Steroids (adverse effects)</term>
<term>Steroids (pharmacology)</term>
<term>Steroids (therapeutic use)</term>
<term>T-Lymphocytes (drug effects)</term>
<term>T-Lymphocytes (immunology)</term>
<term>Uncertainty</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Anticorps monoclonaux humanisés (pharmacologie)</term>
<term>Anticorps monoclonaux humanisés (usage thérapeutique)</term>
<term>Essais contrôlés randomisés comme sujet</term>
<term>Humains</term>
<term>Immunosuppresseurs (pharmacologie)</term>
<term>Immunosuppresseurs (usage thérapeutique)</term>
<term>Incertitude</term>
<term>Infections à coronavirus (anatomopathologie)</term>
<term>Infections à coronavirus (immunologie)</term>
<term>Infections à coronavirus (mortalité)</term>
<term>Infections à coronavirus (traitement médicamenteux)</term>
<term>Interleukine-6 (antagonistes et inhibiteurs)</term>
<term>Interleukine-6 (immunologie)</term>
<term>Lymphocytes T ()</term>
<term>Lymphocytes T (immunologie)</term>
<term>Macrophages ()</term>
<term>Macrophages (immunologie)</term>
<term>Médecins (psychologie)</term>
<term>Pandémies</term>
<term>Pneumopathie virale (anatomopathologie)</term>
<term>Pneumopathie virale (immunologie)</term>
<term>Pneumopathie virale (mortalité)</term>
<term>Pneumopathie virale (traitement médicamenteux)</term>
<term>Prise de décision clinique</term>
<term>Stéroïdes (administration et posologie)</term>
<term>Stéroïdes (effets indésirables)</term>
<term>Stéroïdes (pharmacologie)</term>
<term>Stéroïdes (usage thérapeutique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Steroids</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Steroids</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Interleukin-6</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Interleukin-6</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antibodies, Monoclonal, Humanized</term>
<term>Immunosuppressive Agents</term>
<term>Steroids</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antibodies, Monoclonal, Humanized</term>
<term>Immunosuppressive Agents</term>
<term>Steroids</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Stéroïdes</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>Interleukine-6</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Betacoronavirus</term>
<term>Macrophages</term>
<term>T-Lymphocytes</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Stéroïdes</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Interleukine-6</term>
<term>Lymphocytes T</term>
<term>Macrophages</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Betacoronavirus</term>
<term>Coronavirus Infections</term>
<term>Macrophages</term>
<term>Pneumonia, Viral</term>
<term>T-Lymphocytes</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Anticorps monoclonaux humanisés</term>
<term>Immunosuppresseurs</term>
<term>Stéroïdes</term>
</keywords>
<keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Médecins</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Physicians</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anticorps monoclonaux humanisés</term>
<term>Immunosuppresseurs</term>
<term>Stéroïdes</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Clinical Decision-Making</term>
<term>Humans</term>
<term>Pandemics</term>
<term>Randomized Controlled Trials as Topic</term>
<term>Uncertainty</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Essais contrôlés randomisés comme sujet</term>
<term>Humains</term>
<term>Incertitude</term>
<term>Lymphocytes T</term>
<term>Macrophages</term>
<term>Pandémies</term>
<term>Prise de décision clinique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32273618</PMID>
<DateCompleted><Year>2020</Year>
<Month>04</Month>
<Day>20</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1476-4687</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>580</Volume>
<Issue>7803</Issue>
<PubDate><Year>2020</Year>
<Month>04</Month>
</PubDate>
</JournalIssue>
<Title>Nature</Title>
<ISOAbbreviation>Nature</ISOAbbreviation>
</Journal>
<ArticleTitle>How does COVID-19 kill? Uncertainty is hampering doctors' ability to choose treatments.</ArticleTitle>
<Pagination><MedlinePgn>311-312</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/d41586-020-01056-7</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ledford</LastName>
<ForeName>Heidi</ForeName>
<Initials>H</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016433">News</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Nature</MedlineTA>
<NlmUniqueID>0410462</NlmUniqueID>
<ISSNLinking>0028-0836</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D061067">Antibodies, Monoclonal, Humanized</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D013256">Steroids</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>I031V2H011</RegistryNumber>
<NameOfSubstance UI="C502936">tocilizumab</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D061067" MajorTopicYN="N">Antibodies, Monoclonal, Humanized</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000066491" MajorTopicYN="Y">Clinical Decision-Making</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="Y">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010820" MajorTopicYN="N">Physicians</DescriptorName>
<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013256" MajorTopicYN="N">Steroids</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D035501" MajorTopicYN="Y">Uncertainty</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Diseases</Keyword>
<Keyword MajorTopicYN="Y">Epidemiology</Keyword>
<Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>4</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>4</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>4</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32273618</ArticleId>
<ArticleId IdType="doi">10.1038/d41586-020-01056-7</ArticleId>
<ArticleId IdType="pii">10.1038/d41586-020-01056-7</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000251 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000251 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:32273618 |texte= How does COVID-19 kill? Uncertainty is hampering doctors' ability to choose treatments. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:32273618" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |